MARIA, a 42-year-old teacher with an energetic spirit, had always been an active woman. However, one morning after a long ...

Summary: Administrative claims data for patients with a DVT or PE diagnosis (ICD-9-CM code ... Early detection and appropriate treatment of this high-risk population have the potential for ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

If you suddenly feel short of breath and a bit anxious, it might be something called "dyspnea." Let's dive into what the ...

Ongoing commercial launch of AUCATZYL® on track, with 24 treatment centers fully authorized as of January 10th- National Comprehensive Cancer ...

DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...

LINC is designed with multiple high-quality live cases from the world's leading interventional centers, presented through immersive dialogue wi ...

InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...

A new study published in The Journal of Bone and Joint Surgery showed that when glucagon-like peptide-1 receptor agonist (GLP ...